MC-DOXHZN hydrochloride is primarily utilized in the field of medical research, particularly in the development of novel therapeutic agents. Its application is focused on studying its potential as an anticancer compound, where it is evaluated for its efficacy in inhibiting tumor growth and inducing apoptosis in cancer cells. Researchers explore its mechanism of action, including its ability to interfere with DNA replication and cellular processes in malignant cells. Additionally, it is investigated for its pharmacokinetic properties, such as absorption, distribution, metabolism, and excretion, to assess its suitability as a drug candidate. The compound is also used in preclinical studies to determine its safety profile, toxicity levels, and potential side effects, which are critical for advancing it to clinical trials. Its role in targeted therapy and combination treatments with other anticancer agents is another area of active research.